The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Chickenpox (Varicella) Vaccine-Global Market Insights and Sales Trends 2025
Synopsis
The global Chickenpox (Varicella) Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Chickenpox (Varicella) Vaccine in various end use industries. The expanding demands from the Kids Injection and Adults Injection, are propelling Chickenpox (Varicella) Vaccine market. Monovalent Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Combination Vaccine segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Chickenpox (Varicella) Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Chickenpox (Varicella) Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Chickenpox (Varicella) Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Chickenpox (Varicella) Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Chickenpox (Varicella) Vaccine covered in this report include Merck & Co., Sanofi Pasteur, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross and Biken, etc.
The global Chickenpox (Varicella) Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck & Co.
Sanofi Pasteur
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken
Global Chickenpox (Varicella) Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Chickenpox (Varicella) Vaccine market, Segment by Type:
Monovalent Vaccine
Combination Vaccine
Global Chickenpox (Varicella) Vaccine market, by Application
Kids Injection
Adults Injection
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Chickenpox (Varicella) Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Chickenpox (Varicella) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Chickenpox (Varicella) Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Chickenpox (Varicella) Vaccine in various end use industries. The expanding demands from the Kids Injection and Adults Injection, are propelling Chickenpox (Varicella) Vaccine market. Monovalent Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Combination Vaccine segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Chickenpox (Varicella) Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Chickenpox (Varicella) Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Chickenpox (Varicella) Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Chickenpox (Varicella) Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Chickenpox (Varicella) Vaccine covered in this report include Merck & Co., Sanofi Pasteur, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross and Biken, etc.
The global Chickenpox (Varicella) Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck & Co.
Sanofi Pasteur
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken
Global Chickenpox (Varicella) Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Chickenpox (Varicella) Vaccine market, Segment by Type:
Monovalent Vaccine
Combination Vaccine
Global Chickenpox (Varicella) Vaccine market, by Application
Kids Injection
Adults Injection
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Chickenpox (Varicella) Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Chickenpox (Varicella) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Chickenpox (Varicella) Vaccine Market Overview
1.1 Chickenpox (Varicella) Vaccine Product Overview
1.2 Chickenpox (Varicella) Vaccine Market Segment by Type
1.2.1 Monovalent Vaccine
1.2.2 Combination Vaccine
1.3 Global Chickenpox (Varicella) Vaccine Market Size by Type
1.3.1 Global Chickenpox (Varicella) Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Chickenpox (Varicella) Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Chickenpox (Varicella) Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Chickenpox (Varicella) Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Chickenpox (Varicella) Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Chickenpox (Varicella) Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Chickenpox (Varicella) Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Chickenpox (Varicella) Vaccine Sales Breakdown by Type (2018-2023)
2 Global Chickenpox (Varicella) Vaccine Market Competition by Company
2.1 Global Top Players by Chickenpox (Varicella) Vaccine Sales (2018-2023)
2.2 Global Top Players by Chickenpox (Varicella) Vaccine Revenue (2018-2023)
2.3 Global Top Players by Chickenpox (Varicella) Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Chickenpox (Varicella) Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Chickenpox (Varicella) Vaccine Market Competitive Situation and Trends
2.5.1 Chickenpox (Varicella) Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Chickenpox (Varicella) Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chickenpox (Varicella) Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Chickenpox (Varicella) Vaccine Market
2.8 Key Manufacturers Chickenpox (Varicella) Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Chickenpox (Varicella) Vaccine Status and Outlook by Region
3.1 Global Chickenpox (Varicella) Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Chickenpox (Varicella) Vaccine Historic Market Size by Region
3.2.1 Global Chickenpox (Varicella) Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Chickenpox (Varicella) Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Chickenpox (Varicella) Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Chickenpox (Varicella) Vaccine Forecasted Market Size by Region
3.3.1 Global Chickenpox (Varicella) Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Chickenpox (Varicella) Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Chickenpox (Varicella) Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Chickenpox (Varicella) Vaccine by Application
4.1 Chickenpox (Varicella) Vaccine Market Segment by Application
4.1.1 Kids Injection
4.1.2 Adults Injection
4.2 Global Chickenpox (Varicella) Vaccine Market Size by Application
4.2.1 Global Chickenpox (Varicella) Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Chickenpox (Varicella) Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Chickenpox (Varicella) Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Chickenpox (Varicella) Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Chickenpox (Varicella) Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Chickenpox (Varicella) Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Chickenpox (Varicella) Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Chickenpox (Varicella) Vaccine Sales Breakdown by Application (2018-2023)
5 North America Chickenpox (Varicella) Vaccine by Country
5.1 North America Chickenpox (Varicella) Vaccine Historic Market Size by Country
5.1.1 North America Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Chickenpox (Varicella) Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Chickenpox (Varicella) Vaccine Sales in Value by Country (2018-2023)
5.2 North America Chickenpox (Varicella) Vaccine Forecasted Market Size by Country
5.2.1 North America Chickenpox (Varicella) Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Chickenpox (Varicella) Vaccine Sales in Value by Country (2024-2029)
6 Europe Chickenpox (Varicella) Vaccine by Country
6.1 Europe Chickenpox (Varicella) Vaccine Historic Market Size by Country
6.1.1 Europe Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Chickenpox (Varicella) Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Chickenpox (Varicella) Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Chickenpox (Varicella) Vaccine Forecasted Market Size by Country
6.2.1 Europe Chickenpox (Varicella) Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Chickenpox (Varicella) Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Chickenpox (Varicella) Vaccine by Region
7.1 Asia-Pacific Chickenpox (Varicella) Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Chickenpox (Varicella) Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Chickenpox (Varicella) Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Chickenpox (Varicella) Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Chickenpox (Varicella) Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Chickenpox (Varicella) Vaccine Sales in Value by Region (2024-2029)
8 Latin America Chickenpox (Varicella) Vaccine by Country
8.1 Latin America Chickenpox (Varicella) Vaccine Historic Market Size by Country
8.1.1 Latin America Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Chickenpox (Varicella) Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Chickenpox (Varicella) Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Chickenpox (Varicella) Vaccine Forecasted Market Size by Country
8.2.1 Latin America Chickenpox (Varicella) Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Chickenpox (Varicella) Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Chickenpox (Varicella) Vaccine by Country
9.1 Middle East and Africa Chickenpox (Varicella) Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Chickenpox (Varicella) Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Chickenpox (Varicella) Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Chickenpox (Varicella) Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Chickenpox (Varicella) Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Chickenpox (Varicella) Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck & Co.
10.1.1 Merck & Co. Company Information
10.1.2 Merck & Co. Introduction and Business Overview
10.1.3 Merck & Co. Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck & Co. Chickenpox (Varicella) Vaccine Products Offered
10.1.5 Merck & Co. Recent Development
10.2 Sanofi Pasteur
10.2.1 Sanofi Pasteur Company Information
10.2.2 Sanofi Pasteur Introduction and Business Overview
10.2.3 Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Pasteur Chickenpox (Varicella) Vaccine Products Offered
10.2.5 Sanofi Pasteur Recent Development
10.3 GSK
10.3.1 GSK Company Information
10.3.2 GSK Introduction and Business Overview
10.3.3 GSK Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GSK Chickenpox (Varicella) Vaccine Products Offered
10.3.5 GSK Recent Development
10.4 Shanghai Institute
10.4.1 Shanghai Institute Company Information
10.4.2 Shanghai Institute Introduction and Business Overview
10.4.3 Shanghai Institute Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Shanghai Institute Chickenpox (Varicella) Vaccine Products Offered
10.4.5 Shanghai Institute Recent Development
10.5 BCHT
10.5.1 BCHT Company Information
10.5.2 BCHT Introduction and Business Overview
10.5.3 BCHT Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 BCHT Chickenpox (Varicella) Vaccine Products Offered
10.5.5 BCHT Recent Development
10.6 Changsheng
10.6.1 Changsheng Company Information
10.6.2 Changsheng Introduction and Business Overview
10.6.3 Changsheng Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Changsheng Chickenpox (Varicella) Vaccine Products Offered
10.6.5 Changsheng Recent Development
10.7 Keygen
10.7.1 Keygen Company Information
10.7.2 Keygen Introduction and Business Overview
10.7.3 Keygen Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Keygen Chickenpox (Varicella) Vaccine Products Offered
10.7.5 Keygen Recent Development
10.8 Green Cross
10.8.1 Green Cross Company Information
10.8.2 Green Cross Introduction and Business Overview
10.8.3 Green Cross Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Green Cross Chickenpox (Varicella) Vaccine Products Offered
10.8.5 Green Cross Recent Development
10.9 Biken
10.9.1 Biken Company Information
10.9.2 Biken Introduction and Business Overview
10.9.3 Biken Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Biken Chickenpox (Varicella) Vaccine Products Offered
10.9.5 Biken Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Chickenpox (Varicella) Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Chickenpox (Varicella) Vaccine Industrial Chain Analysis
11.4 Chickenpox (Varicella) Vaccine Market Dynamics
11.4.1 Chickenpox (Varicella) Vaccine Industry Trends
11.4.2 Chickenpox (Varicella) Vaccine Market Drivers
11.4.3 Chickenpox (Varicella) Vaccine Market Challenges
11.4.4 Chickenpox (Varicella) Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Chickenpox (Varicella) Vaccine Distributors
12.3 Chickenpox (Varicella) Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
